BXTAccelyon Blog

A study published in September 2017, titled: ‘Quality of life after brachytherapy or bilateral nerve‐sparing robot‐assisted radical prostate

BXTAccelyon, the leading low dose rate (LDR) brachytherapy partner to hospitals and clinics worldwide and the sole distribution partner outside North America for the new PrecisionPoint™ Transperineal Access System, is pleased to announce that for the fifth consecutive year it is the platinum sponsor for the 2018 UK & Ireland Prostate Brachytherapy Conference. The conference, which is being hosted by Maidstone and Tunbridge Wells NHS Trust, will take place on Friday 23rd March

BXTAccelyon, the leading low dose rate (LDR) brachytherapy partner to hospitals and clinics worldwide and the sole distribution partner outs

12th July 2017: BXTAccelyon, the leading low dose rate (LDR) brachytherapy partner to hospitals and clinics worldwide, is proud to announce it has become the sole distribution partner outside North America for the PrecisionPointTM Transperineal Access System, a new medical device that is set to revolutionise prostate biopsies. Developed in response to the increased adoption of active surveillance and the disadvantages in transrectal biopsy approaches, PrecisionPointTM which h

BXTAccelyon has been selected by Feedspot panelists as one of the Top 50 Prostate Cancer Blogs on the web. We are proud to say we are currently placed at number 30 based on a number of search and social metrics. It is great to know that we are in position to reach people with relevant information on prostate cancer and LDR brachytherapy. Find out more here #prostatecancerblog #prostatecancer #BXTAccelyon #Feedspot

In June 2016 we sent our first newsletter. One year on, we've got a growing list of subscribers who receive our quarterly updates.

For the fourth consecutive year, we were the platinum sponsor to the Prostate Brachytherapy UK & Ireland Conference 2017, which was host

Over the last few years BXTAccelyon has grown into one of the UK’s leading partners to hospitals and clinics worldwide, providing low-dose r

4D Brachytherapy is a hybrid approach to LDR brachytherapy for prostate cancer. It combines the benefits of both a two-stage and one-stage

World Cancer Day on 4th February will unite the world’s population in the fight against cancer. World Cancer Day aims to raise global awareness and educate people about the disease, encouraging governments and individuals worldwide to take action and in doing so, help to save millions of preventable deaths each year. The team at BXTAccelyon are getting into the sporting spirit for World Cancer Day this year. One colleague will be doing a London to Brighton Walking Challenge t